Literature DB >> 33972373

Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination.

Bennett J Davenport1, Thomas E Morrison1, Ross M Kedl2, Jared Klarquist2.   

Abstract

The prior existence of human ACE2 protein-expressing mice used to study SARS-CoV and the rapid development of mouse-adapted virus strains have allowed the study of SARS-CoV-2 in mice, even as we are still learning about its natural pathology in humans. With myriad genetically altered strains on the C57BL/6 background and the abundance of immunological reagents available to interrogate its immune responses, the C57BL/6 mice may provide useful insight into the immunology of SARS-CoV-2 infection and vaccination. To conduct more detailed studies on their T cell responses to vaccines and infection, the epitopes eliciting those responses must be characterized in further detail. In this study, we mapped CD8 T cell epitopes within the receptor binding domain of the SARS-CoV-2 spike protein in C57BL/6 mice. Our study identified five major CD8 T cell epitopes in immunized C57BL/6 mice, including one, VVLSFELL, presented by H-2Kb and common between SARS-CoV and SARS-CoV-2.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33972373      PMCID: PMC8165008          DOI: 10.4049/jimmunol.2100195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  23 in total

1.  A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88.

Authors:  Peter Ross; Jennifer C Holmes; Gregory S Gojanovich; Paul R Hess
Journal:  Vet Immunol Immunopathol       Date:  2012-09-21       Impact factor: 2.046

2.  Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.

Authors:  Lihong Liu; Pengfei Wang; Manoj S Nair; Jian Yu; Micah Rapp; Qian Wang; Yang Luo; Jasper F-W Chan; Vincent Sahi; Amir Figueroa; Xinzheng V Guo; Gabriele Cerutti; Jude Bimela; Jason Gorman; Tongqing Zhou; Zhiwei Chen; Kwok-Yung Yuen; Peter D Kwong; Joseph G Sodroski; Michael T Yin; Zizhang Sheng; Yaoxing Huang; Lawrence Shapiro; David D Ho
Journal:  Nature       Date:  2020-07-22       Impact factor: 49.962

Review 3.  SARS-CoV-2 vaccines in development.

Authors:  Florian Krammer
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

4.  Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.

Authors:  Vineet Joag; Sathi Wijeyesinghe; J Michael Stolley; Clare F Quarnstrom; Thamotharampillai Dileepan; Andrew G Soerens; Jules A Sangala; Stephen D O'Flanagan; Noah V Gavil; Sung-Wook Hong; Siddheshvar Bhela; Sailaja Gangadhara; Eyob Weyu; William E Matchett; Joshua Thiede; Venkatramana Krishna; Maxim C-J Cheeran; Tyler D Bold; Rama Amara; Peter Southern; Geoffrey T Hart; Luca Schifanella; Vaiva Vezys; Marc K Jenkins; Ryan A Langlois; David Masopust
Journal:  J Immunol       Date:  2021-01-13       Impact factor: 5.422

5.  T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Authors:  Katie J Ewer; Jordan R Barrett; Sandra Belij-Rammerstorfer; Adrian V S Hill; Sarah C Gilbert; Andrew J Pollard; Teresa Lambe; Hannah Sharpe; Rebecca Makinson; Richard Morter; Amy Flaxman; Daniel Wright; Duncan Bellamy; Mustapha Bittaye; Christina Dold; Nicholas M Provine; Jeremy Aboagye; Jamie Fowler; Sarah E Silk; Jennifer Alderson; Parvinder K Aley; Brian Angus; Eleanor Berrie; Sagida Bibi; Paola Cicconi; Elizabeth A Clutterbuck; Irina Chelysheva; Pedro M Folegatti; Michelle Fuskova; Catherine M Green; Daniel Jenkin; Simon Kerridge; Alison Lawrie; Angela M Minassian; Maria Moore; Yama Mujadidi; Emma Plested; Ian Poulton; Maheshi N Ramasamy; Hannah Robinson; Rinn Song; Matthew D Snape; Richard Tarrant; Merryn Voysey; Marion E E Watson; Alexander D Douglas
Journal:  Nat Med       Date:  2020-12-17       Impact factor: 53.440

6.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

7.  Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.

Authors:  Ania Wajnberg; Fatima Amanat; Adolfo Firpo; Deena R Altman; Mark J Bailey; Mayce Mansour; Meagan McMahon; Philip Meade; Damodara Rao Mendu; Kimberly Muellers; Daniel Stadlbauer; Kimberly Stone; Shirin Strohmeier; Viviana Simon; Judith Aberg; David L Reich; Florian Krammer; Carlos Cordon-Cardo
Journal:  Science       Date:  2020-10-28       Impact factor: 47.728

8.  Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.

Authors:  Sheila F Lumley; Denise O'Donnell; Nicole E Stoesser; Philippa C Matthews; Alison Howarth; Stephanie B Hatch; Brian D Marsden; Stuart Cox; Tim James; Fiona Warren; Liam J Peck; Thomas G Ritter; Zoe de Toledo; Laura Warren; David Axten; Richard J Cornall; E Yvonne Jones; David I Stuart; Gavin Screaton; Daniel Ebner; Sarah Hoosdally; Meera Chand; Derrick W Crook; Anne-Marie O'Donnell; Christopher P Conlon; Koen B Pouwels; A Sarah Walker; Tim E A Peto; Susan Hopkins; Timothy M Walker; Katie Jeffery; David W Eyre
Journal:  N Engl J Med       Date:  2020-12-23       Impact factor: 91.245

9.  Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.

Authors:  Jeffrey Seow; Carl Graham; Blair Merrick; Sam Acors; Suzanne Pickering; Kathryn J A Steel; Oliver Hemmings; Aoife O'Byrne; Neophytos Kouphou; Rui Pedro Galao; Gilberto Betancor; Harry D Wilson; Adrian W Signell; Helena Winstone; Claire Kerridge; Isabella Huettner; Jose M Jimenez-Guardeño; Maria Jose Lista; Nigel Temperton; Luke B Snell; Karen Bisnauthsing; Amelia Moore; Adrian Green; Lauren Martinez; Brielle Stokes; Johanna Honey; Alba Izquierdo-Barras; Gill Arbane; Amita Patel; Mark Kia Ik Tan; Lorcan O'Connell; Geraldine O'Hara; Eithne MacMahon; Sam Douthwaite; Gaia Nebbia; Rahul Batra; Rocio Martinez-Nunez; Manu Shankar-Hari; Jonathan D Edgeworth; Stuart J D Neil; Michael H Malim; Katie J Doores
Journal:  Nat Microbiol       Date:  2020-10-26       Impact factor: 17.745

10.  Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.

Authors:  Carolyn Rydyznski Moderbacher; Sydney I Ramirez; Jennifer M Dan; Alba Grifoni; Kathryn M Hastie; Daniela Weiskopf; Simon Belanger; Robert K Abbott; Christina Kim; Jinyong Choi; Yu Kato; Eleanor G Crotty; Cheryl Kim; Stephen A Rawlings; Jose Mateus; Long Ping Victor Tse; April Frazier; Ralph Baric; Bjoern Peters; Jason Greenbaum; Erica Ollmann Saphire; Davey M Smith; Alessandro Sette; Shane Crotty
Journal:  Cell       Date:  2020-09-16       Impact factor: 66.850

View more
  2 in total

1.  Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells.

Authors:  Somasundaram Raghavan; M Dennis Leo
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

2.  B cells promote CD8 T cell primary and memory responses to subunit vaccines.

Authors:  Jared Klarquist; Eric W Cross; Scott B Thompson; Benjamin Willett; Daniel L Aldridge; Alayna K Caffrey-Carr; Zhenming Xu; Christopher A Hunter; Andrew Getahun; Ross M Kedl
Journal:  Cell Rep       Date:  2021-08-24       Impact factor: 9.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.